Wistar Institute scientists and collaborators describe a next-generation vaccination technology that combines plasmid DNA with a lipid nanoparticle delivery system.
Filippo Veglia, Ph.D., and lab have discovered the process of how brain tumors reprogram certain immune cells called neutrophils from cancer enemies to cancer allies.
Colby Maldini, Ph.D., who joins Wistar鈥檚 HIV Cure and Viral Diseases Center as a Caspar Wistar Fellow
Researchers at The Wistar Institute鈥檚 HIV Cure and Viral Diseases Center have successfully identified a new approach using natural killer (NK) cells to target and kill the HIV-positive cells that allow the virus to persist. Wistar scientists have labeled this new approach 鈥淣uKES鈥�: Natural Killer Enhancement Strategy.
The Wistar Institute scientists have identified a new strategy for attacking treatment-resistant melanoma: inhibiting the gene S6K2.
Wistar Institute assistant professors Nan Zhang, Ph.D., and Noam Auslander Ph.D., have both received independent funding totaling $1.2 million over the next three years for cancer research projects from the V Foundation for Cancer Research.
The Wistar Institute鈥檚 David B. Weiner, Ph.D., and his laboratory created a new therapeutic design for glioblastoma, the deadliest form of brain cancer. The lab engineered molecules called trispecifics that connect cancer-killing T cells with not just one but two different brain cancer receptors.
The Wistar Institute's Dr. Alessandro Gardini and his lab have published their new paper, 鈥淭he enhancer module of integrator controls cell identity and early neural fate commitment,鈥� in the journal Nature Cell Biology.
The Wistar Institute scientists have discovered a new approach to treating ovarian cancer that, in preclinical laboratory testing, shrinks tumors and improves survival rates while simultaneously making tumors more receptive to chemotherapy treatment.
A collaboration between The Wistar Institute and the University of Buea in Cameroon has uncovered the mechanisms for a medicinal plant with anti-HIV potential in Croton oligandrus Pierre & Hutch, a species of African tree that has been used in traditional healing in Cameroon to treat a variety of diseases and conditions including cancers and diabetes.
The Wistar Institute鈥檚 Hubert J.P. Schoemaker Education and Training Center was the recipient of a $100,000 eXperience grant from NIIMBL to support an immersive weeklong training program at the Institute.
New research from the Salvino lab identifies novel series of MPro inhibitors
Wistar scientists have demonstrated the role of Parkin 鈥� a protein implicated in Parkinson's disease 鈥� in the body鈥檚 innate immune response to cancer.
Wistar Institute scientists have successfully isolated and cloned fully human antibodies that can block specific Type-I interferon molecules in vitro; their discovery has an array of potential clinical & research applications, enabling scientists with a new way to investigate the role of specific Type-I interferons in a variety of diseases.
The Wistar Institute and Wexford Science & Technology, LLC, announced that Wistar has signed a lease for new laboratory and office space at uCity Square in Philadelphia to expand its capacity and resources essential for making groundbreaking discoveries that advance human health.
Wistar Celebrates Accomplishments of 58 Diverse, Next-Gen Students & Pre-apprentices Completing Summer Science Education & Training Programs.
Wistar Institute honors 2023 Nobel laureate Katalin Karik贸, Ph.D., as the 2024 Helen Dean King Award recipient on October 8, 2024 at noon (ET).
July 16th at 6:30 pm EDT, Nobel Laureate in Medicine or Physiology Drew Weissman, M.D., Ph.D., delivers the 28th annual Jonathan Lax Memorial Lecture at The Wistar Institute in recognition of his outstanding contributions to HIV research.
The Wistar Institute is pleased to announce a research collaboration with Accelerated Biosciences Corp. aimed at creating a platform based on human trophoblast stem cells to explore new immunotherapies that use Accelerated Bio鈥檚 proprietary technology.
Jozef Madzo, Ph.D., recruited as an assistant professor and director of Bioinformatics, at The Wistar Institute.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 麻豆传媒 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right